Personal information

China

Activities

Employment (1)

China Pharmaceutical University: Nanjing, Jiangsu, CN

2017-07-03 to present | Post Doctor (Department of Pharmaceutics)
Employment
Source: Self-asserted source
Hui Xiong

Funding (1)

Dual-Nano delivery remodeling tumor metabolic homeostasis to promote classical therapy-mediated tumor vascular normalization

2019-01 to 2021-12 | Grant
National Natural Science Foundation of China (Nanjing, CN)
GRANT_NUMBER:

81803457

Source: Self-asserted source
Hui Xiong

Works (14)

Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation

Small
2024-06 | Journal article
Contributors: Lan Yao; Xiang Zhu; Yunyi Shan; Liang Zhang; Jing Yao; Hui Xiong
Source: check_circle
Crossref

Rediscovering Tocophersolan: A Renaissance for Nano-Based Drug Delivery and Nanotheranostic Applications

Current Drug Targets
2021-06 | Journal article
Contributors: Dickson P. Wande; Qin Cui; Shijie Chen; Cheng Xu; Hui Xiong; Jing Yao
Source: check_circle
Crossref

Transforming Complexity to Simplicity: Protein-Like Nanotransformer for Improving Tumor Drug Delivery Programmatically

Nano Letters
2020-03-11 | Journal article
Contributors: Hui Xiong; Zihan Wang; Cheng Wang; Jing Yao
Source: check_circle
Crossref

Attempts to strengthen and simplify the tumor vascular normalization strategy using tumor vessel normalization promoting nanomedicines

Biomaterials Science
2019 | Journal article
Part of ISSN: 2047-4830
Part of ISSN: 2047-4849
Source: Self-asserted source
Hui Xiong

Intracellular cascade activated nanosystem for improving ER+ breast cancer therapy through attacking GSH-mediated metabolic vulnerability

Journal of Controlled Release
2019-09 | Journal article
Part of ISSN: 0168-3659
Source: Self-asserted source
Hui Xiong

Assembly simulation and synergistic chemotherapy of TPGS derivative functionalized polymersomes in hepatocellular carcinoma

Nanomedicine
2019-07 | Journal article
Part of ISSN: 1743-5889
Part of ISSN: 1748-6963
Source: Self-asserted source
Hui Xiong

pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release

Journal of Colloid and Interface Science
2019-02 | Journal article
Part of ISSN: 0021-9797
Source: Self-asserted source
Hui Xiong

Intracellular self-disassemble polysaccharide nanoassembly for multi-factors tumor drug resistance modulation of doxorubicin

Biomaterials Science
2018 | Journal article
Contributors: Hui Xiong; Jiang Ni; Zhijie Jiang; Fengchun Tian; Jianping Zhou; Jing Yao
Source: check_circle
Crossref

Mechanisms of TPGS and its derivatives inhibiting P-glycoprotein efflux pump and application for reversing multidrug resistance in hepatocellular carcinoma

Polymer Chemistry
2018 | Journal article
Part of ISSN: 1759-9954
Part of ISSN: 1759-9962
Source: Self-asserted source
Hui Xiong

Primary tumor and pre-metastatic niches co-targeting “peptides-lego” hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment

Biomaterials Science
2018 | Journal article
Contributors: Hui Xiong; Shi Du; Ping Zhang; Zhijie Jiang; Jianping Zhou; Jing Yao
Source: check_circle
Crossref

A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer

Acta Biomaterialia
2018-07 | Journal article
Part of ISSN: 1742-7061
Source: Self-asserted source
Hui Xiong

Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy

European Journal of Pharmaceutical Sciences
2018-07 | Journal article
Part of ISSN: 0928-0987
Source: Self-asserted source
Hui Xiong

Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin

Biomaterials
2016-07 | Journal article
Part of ISSN: 0142-9612
Source: Self-asserted source
Hui Xiong

Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles

Nanotechnology
2015-04-07 | Journal article
Part of ISSN: 0957-4484
Part of ISSN: 1361-6528
Source: Self-asserted source
Hui Xiong

Peer review (3 reviews for 1 publication/grant)

Review activity for International journal of pharmaceutics (3)